DCPLA-ME
DCPLA-ME, the methyl ester form of DCPLA, is a potent PKCε activator for use in the treatment of neurodegenerative diseases[1].
Product Specifications
CAS Number
56687-67-3
Product Name Alternative
DCPLA methyl ester
UNSPSC
12352211
Target
PKC
Type
Reference compound
Related Pathways
Epigenetics; TGF-beta/Smad
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/dcpla-me.html
Purity
98.0
Solubility
DMSO : 15.62 mg/mL (ultrasonic)
Smiles
O=C(OC)CCCCCCCC1C(CC2C(CCCCC)C2)C1
Molecular Formula
C21H38O2
Molecular Weight
322.53
References & Citations
[1]Thomas J. Nelson, et al. Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases. WO2015058191A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PKCε
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP310159 20 µg
Beta crystallin S (CRYGS) (NM_017541) Human Recombinant Protein
Sign In for Pricing
View Details 